Farrell Sheridan serves as the Director of Investor Relations and Business Development at BioMap, an AI company focused on drug discovery and synthetic biology, since March 2023. Previously, Farrell held the position of Strategy Advisor for the Oman Public Authority for Special Economic Zones, providing guidance on investment strategies from May 2022 to March 2023. Farrell has extensive experience in strategic development, having served as Head of Strategic Development at Abu Dhabi Global Market from February 2016 to April 2022, and as Senior Analyst at Qatar Financial Centre Authority from October 2012 to January 2016. Additional roles include equity research at Jefferies and consultancy at Alpha FMC and Deloitte UK. Farrell holds an MBA from Durham University and various executive education credentials, including programs at London Business School and The University of Chicago Booth School of Business, along with qualifications as a Chartered Accountant.
